Showing 22 results

Supporting health professionals during COVID-19

We're continuing to support health professionals during COVID-19, keeping you updated with the latest information and resources.

man of men telescope

Active surveillance consensus guideline

Read our consensus guidelines for health professionals.

Man of Men group

Prostate Cancer UK active surveillance consensus statement

Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement.

MPMRI Man of Men

mpMRI protocols

Our mpMRI scanner protocols for optimising image quality for prostate MRI, produced with the Society and College of Radiographers.

Health and Social Care Professionals Programme

PCRMP & Prostate Cancer UK Consensus statements

Summary leaflet of Public Heath England’s Prostate Cancer Risk Management Programme guidance (2016) and Prostate Cancer UK’s ‘Consensus statements on PSA testing in asymptomatic men in the UK' (2016) for GPs.

Consensus statements on PSA testing in asymptomatic men (2016)

Prostate Cancer UK's 2016 consensus statements on PSA testing in asymptomatic men in the UK.

Public Health England Logo

Prostate Cancer Risk Management Programme (PHE, 2016)

Public Health England's page on the Prostate Cancer Risk Management Programme (PCRMP) including Full Evidence Document for GPs and Summary Information Sheets for GPs and men over 50.

National Institute for Health and Clinical Excellence logo white

Prostate Cancer: diagnosis and management NG131 (NICE, Updated 2019)

The National Institute of Healthcare and Clinical Excellence's 2014 guideline on prostate cancer. (Updated 2019)

European Association of Urology logo

Prostate Cancer Guidelines (European Association of Urology, Updated 2019)

The European Association of Urology's 2015 guidelines on prostate cancer. (Updated 2019)

Prostate cancer uk logo white

Erectile dysfunction after surgery for pelvic cancers (2014)

Prostate Cancer UK and Macmillan's 2014 guidelines on treating erectile dysfunction after surgery for pelvic cancers

Prostate cancer uk logo white

Erectile dysfunction after radical radiotherapy and ADT (2014)

Prostate Cancer UK and Macmillan's 2014 guidelines for treating erectile dysfunction after radical radiotherapy and androgen deprivation therapy for prostate cancer

European Association of Urology logo

Guidelines on Male Sexual Dysfunction (EAU, 2013)

The European Association of Urology's 2013 Guidelines on male sexual dysfunction

British Society for Sexual Medicine

Guidelines on the Management of Erectile Dysfunction (BSSM, Updated 2018)

The British Society for Sexual Medicine's 2007 guidelines on the management of erectile dysfunction. (Updated 2018)

European Association of Urology logo

Guidelines on Urinary Incontinence (EAU, 2013)

The European Association of Urology's 2013 guidelines on urinary incontinence.

National Institute for Health and Clinical Excellence logo white

Lower urinary tract symptoms CG97 (NICE, 2010)

The National Institute for Health and Care Excellence's 2010 guideline on lower urinary tract symptoms.

American Urological Association Logo

Management of Benign Prostatic Hyperplasia (AUA, Updated 2014)

The American Urological Association's 2011 guidelines on management of Benign Prostatic Hyperplasia (BPH). (Updated 2014)

European Association of Urology logo

Guidelines on management of Non-neurogenic Male LUTS (EAU, Updated 2017)

The European Association of Urology's 2000 guidelines on the management of male lower urinary tract symptoms. (Updated 2017)

European Association of Urology logo

Guidelines on Chronic Pelvic Pain (EAU, 2013)

The European Urological Association's 2013 guidelines on chronic pelvic pain

Prostate cancer uk logo white

Chronic Prostatitis and Chronic Pelvic Pain Syndrome (2014)

Prostate Cancer UK's 2014 consensus guidelines on Chronic Bacterial Prostatitis (CBP) and Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)

British Society for Sexual Medicine

Guidelines on testosterone replacement therapy, (BSSM, 2017)

Guidelines on testosterone replacement therapy, with statements for best practice (2017).